Gene · 2865
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy. | Front Microbiol | 2025 | 40809055 | PubTator, text mining | PubMed |
| Association between dietary index for gut microbiota and cardiovascular-kidney-metabolic syndrome: a population-based study. | Front Nutr | 2025 | 40808844 | PubTator, text mining | PubMed |
| Unraveling the Translational Relevance of β-Hydroxybutyrate as an Intermediate Metabolite and Signaling Molecule. | Int J Mol Sci | 2025 | 40806491 | PubTator, text mining | PubMed |
| Fermented means beneficial - fermented foods as support for the metabolism of children and adolescents? | Pediatr Endocrinol Diabetes Metab | 2025 | 40755341 | PubTator, text mining | PubMed |
| A comprehensive investigation of the relationship between dietary fatty acid intake and preserved ratio impaired spirometry: multimethodology based on NHANES. | Lipids Health Dis | 2025 | 40751263 | PubTator, text mining | PubMed |
| Modulation of oral vaccine efficacy by the gut microbiota. | NPJ Vaccines | 2025 | 40750603 | PubTator, text mining | PubMed |
| Probiotic-derived postbiotics: a perspective on next-generation therapeutics. | Front Nutr | 2025 | 40747333 | PubTator, text mining | PubMed |
| Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease. | Front Immunol | 2025 | 40746546 | PubTator, text mining | PubMed |
| High-fat diet may increase the risk of insulin resistance by inducing dysbiosis. | Metabol Open | 2025 | 40741424 | PubTator, text mining | PubMed |
| Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular disease. | Front Cardiovasc Med | 2025 | 40741383 | PubTator, text mining | PubMed |
| The gut-bone axis in osteoporosis: a multifaceted interaction with implications for bone health. | Front Endocrinol (Lausanne) | 2025 | 40741168 | PubTator, text mining | PubMed |
| Gut microbiota: emerging biomarkers and potential therapeutics for premature ovarian failure. | Front Microbiol | 2025 | 40735614 | PubTator, text mining | PubMed |
| Gut microbiota-metabolome crosstalk in allergic diseases: mechanistic insights and translational opportunities. | Front Allergy | 2025 | 40735411 | PubTator, text mining | PubMed |
| Expression of FFAR2 and FFAR3 in peripheral blood leukocytes: Correlation with coronary artery stenosis, calcium score, and serum IL-1β levels in male patients. | Nutr Metab Cardiovasc Dis | 2025 | 40695669 | PubTator, text mining | PubMed |
| Acidosis Licenses the NLRP3 Inflammasome-Inhibiting Effects of Beta-Hydroxybutyrate and Short-Chain Carboxylic Acids. | bioRxiv | 2025 | 40654769 | PubTator, text mining | PubMed |
| The role of free fatty acid receptors activation in pancreatic disorders. | Mol Aspects Med | 2025 | 40652884 | PubTator, text mining | PubMed |
| Feasibility of Treating Eosinophilic Chronic Rhinosinusitis Using Short-Chain Fatty Acids. | Laryngoscope | 2025 | 40641312 | PubTator, text mining | PubMed |
| β-hydroxybutyrate, a ketone body, suppresses tumor growth, stemness, and invasive phenotypes in non-small cell lung cancer. | Cancer Biol Ther | 2025 | 40545696 | PubTator, text mining | PubMed |
| High-Fat Diet-Induced Gut Microbiota Disruption Promotes Colorectal Cancer Lymphatic Metastasis via Propionate/GPR41 Signaling. | Digestion | 2025 | 40435940 | PubTator, text mining | PubMed |
| Tapping into Metabolomics for Understanding Host and Rotavirus Group A Interactome. | Life (Basel) | 2025 | 40430193 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2865/papers?page=5